Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,046Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa IL

02 1EXCELLA GMBH & CO. KG Feucht DE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

R1-CEP 2000-160 - Rev 04
Valid
Chemical
2022-06-17
896
TAPI Company Banner

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Deferoxamine Mesilate, Produced By Fermentation

Certificate Number : R1-CEP 2000-160 - Rev 04

Status : Valid

Issue Date : 2022-06-17

Type : Chemical

Substance Number : 896

TAPI Company Banner

Looking for 138-14-7 / Deferoxamine Mesylate API manufacturers, exporters & distributors?

Deferoxamine Mesylate manufacturers, exporters & distributors 1

17

PharmaCompass offers a list of Deferoxamine Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Deferoxamine Mesylate manufacturer or Deferoxamine Mesylate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Deferoxamine Mesylate manufacturer or Deferoxamine Mesylate supplier.

PharmaCompass also assists you with knowing the Deferoxamine Mesylate API Price utilized in the formulation of products. Deferoxamine Mesylate API Price is not always fixed or binding as the Deferoxamine Mesylate Price is obtained through a variety of data sources. The Deferoxamine Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Deferoxamine Mesylate

Synonyms

138-14-7, Desferal, Desferrioxamine b mesylate, Deferoxamine mesilate, Desferrioxamine mesylate, Deferoxamine methanesulfonate

Cas Number

138-14-7

Unique Ingredient Identifier (UNII)

V9TKO7EO6K

About Deferoxamine Mesylate

Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.

Deferoxamine Mesylate Manufacturers

A Deferoxamine Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Deferoxamine Mesylate, including repackagers and relabelers. The FDA regulates Deferoxamine Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Deferoxamine Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Deferoxamine Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Deferoxamine Mesylate Suppliers

A Deferoxamine Mesylate supplier is an individual or a company that provides Deferoxamine Mesylate active pharmaceutical ingredient (API) or Deferoxamine Mesylate finished formulations upon request. The Deferoxamine Mesylate suppliers may include Deferoxamine Mesylate API manufacturers, exporters, distributors and traders.

click here to find a list of Deferoxamine Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Deferoxamine Mesylate CEP

A Deferoxamine Mesylate CEP of the European Pharmacopoeia monograph is often referred to as a Deferoxamine Mesylate Certificate of Suitability (COS). The purpose of a Deferoxamine Mesylate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Deferoxamine Mesylate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Deferoxamine Mesylate to their clients by showing that a Deferoxamine Mesylate CEP has been issued for it. The manufacturer submits a Deferoxamine Mesylate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Deferoxamine Mesylate CEP holder for the record. Additionally, the data presented in the Deferoxamine Mesylate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Deferoxamine Mesylate DMF.

A Deferoxamine Mesylate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Deferoxamine Mesylate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Deferoxamine Mesylate suppliers with CEP (COS) on PharmaCompass.

Deferoxamine Mesylate Manufacturers | Traders | Suppliers

Deferoxamine Mesylate Manufacturers, Traders, Suppliers 1
100

We have 2 companies offering Deferoxamine Mesylate

Get in contact with the supplier of your choice:

  1. TAPI Technology & API Services
  2. Fareva
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.